Skip to content
MedsAcross

Medicine

Prochlorperazine 10 mg/2 mL injection

Prochlorperazine · Intramuscular, intravenous
Available on requestPrescription onlyUS FDAGeneric name

Prochlorperazine 10 mg/2 mL injection is a generic prescription medicine for intramuscular, intravenous use, made by 16 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C…

Key facts

Active ingredient (INN)
Prochlorperazine
Brand
Sold under the generic name
Strength
10 mg/2 mL
Dosage form
Injection
Route
Intramuscular, intravenous
Packs
25 vials of 2 mL, 10 vials of 2 mL, 1 vial of 2 mL and 22 more
Manufacturers
Avet PharmaceuticalsIndiaEugiaIndiaGland PharmaIndiaCaplin SterilesIndiaAmneal PharmaceuticalsCosette PharmaceuticalsMylan InstitutionalSagent PharmaceuticalsAvenacyBaxter Healthcare
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F). Protect from light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N05AB04 Prochlorperazine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
29 August 1989
Identifiers
RxCUI 2102949, 314192DailyMed set ID fed5ed29-7091-4b3c-bf67-64f32cd189bb, 11cb37c7-01b4-4223-b2ea-a3695639b80b, e181c18d-32a8-587e-e053-2995a90acc5b +14NDC 25021-790, 43066-090, 51662-1558 +14Application ANDA214107, ANDA214379, ANDA089903 +6

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
25 vial in 1 package / 2 mL in 1 vial23155-294-41Avet PharmaceuticalsIndia26 March 2012
10 vial in 1 package / 2 mL in 1 vial23155-294-42Avet PharmaceuticalsIndia26 March 2012
10 vial in 1 package / 2 mL in 1 vial23155-523-41Avet PharmaceuticalsIndia26 June 2015
25 vial in 1 package / 2 mL in 1 vial23155-523-42Avet PharmaceuticalsIndia26 June 2015
10 vial in 1 carton / 2 mL in 1 vial65145-119-10Caplin SterilesIndia8 April 2026
1 vial, multi-dose in 1 carton / 2 mL in 1 vial, multi-dose55150-360-01EugiaIndia14 July 2022
25 vial, multi-dose in 1 carton / 2 mL in 1 vial, multi-dose55150-360-25EugiaIndia14 July 2022
10 vial in 1 carton / 2 mL in 1 vial68083-435-10Gland PharmaIndia22 September 2021
25 vial in 1 carton / 2 mL in 1 vial68083-435-25Gland PharmaIndia22 September 2021
25 vial in 1 carton / 2 mL in 1 vial70121-1580-5Amneal Pharmaceuticals12 December 2022
10 vial in 1 carton / 2 mL in 1 vial70121-1580-7Amneal Pharmaceuticals12 December 2022
25 vial in 1 carton / 2 mL in 1 vial43066-090-25Baxter Healthcare3 May 2021
10 vial in 1 package / 2 mL in 1 vial0713-0351-09Cosette Pharmaceuticals11 February 2022
25 vial in 1 package / 2 mL in 1 vial0713-0351-25Cosette Pharmaceuticals11 February 2022
10 vial in 1 carton / 2 mL in 1 vial72266-204-10Fosun Pharma1 May 2023
25 vial in 1 carton / 2 mL in 1 vial0641-6135-25Hikma Pharmaceuticals29 August 1989
25 vial in 1 carton / 2 mL in 1 vial67457-640-02Mylan Institutional3 April 2019
10 vial in 1 carton / 2 mL in 1 vial67457-640-99Mylan Institutional3 April 2019
10 vial in 1 carton / 2 mL in 1 vial25021-790-02Sagent Pharmaceuticals15 November 2021
25 vial in 1 carton / 2 mL in 1 vial25021-790-03Sagent Pharmaceuticals15 November 2021
25 vial in 1 carton / 2 mL in 1 vial70069-371-25Somerset Therapeutics10 October 2024
10 vial in 1 carton / 2 mL in 1 vial83634-778-02Avenacy1 June 2024
5 vial in 1 bag / 2 mL in 1 vial55154-4183-5Cardinal Health26 March 2012
25 vial in 1 carton / 2 mL in 1 vial72572-580-25Civica18 November 2019
25 pouch in 1 case / 1 vial in 1 pouch / 2 mL in 1 vial51662-1558-3HealthFirst15 June 2022

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 23 October 1956Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Prochlorperazine

Clinical summary

Prochlorperazine is a phenothiazine. It is available as tablets, injection and suppositories for oral, intramuscular and intravenous use. MedsAcross supplies Prochlorperazine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Prochlorperazine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Prochlorperazine 10 mg/2 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.